Soumitra S Ghosh from 12334 Pathos Ln, San Diego, CA 92129, age 70, Phone: 858 538-0348

Name / Title

Company / Classification

Phones & Addresses

Soumitra Ghosh
President

PEPTIDE THERAPEUTICS FOUNDATION
Civic/Social Association

4245 Sorrento Vly Blvd, San Diego, CA 92121

Soumitra S. Ghosh

Doon Associates LLC
Business Services at Non-Commercial Site

12334 Pathos Ln, San Diego, CA 92129

Resumes

Global Biotech Business Controller At Bayer Healthcare (On Assignment: Bayer Pharma Ag, Germany)

view source

Position:

Global Biotech Business Controller at Bayer HealthCare

Location:

Berlin Area, Germany

Industry:

Biotechnology

Work:

Bayer HealthCare - Berkeley, California since Jun 2012
Global Biotech Business Controller
Bayer Technology Services - Berkeley, CA Jun 2006 - May 2012
Project Manager / Principal Engineer
Centocor Inc (Johnson & Johnson) Jun 2005 - Sep 2005
Summer Intern

Education:

University of California, Berkeley Extension 2008 - 2009
Certificate, Business Administration Carnegie Mellon University 2001 - 2006
PhD, Chemical Engineering Indian Institute of Technology, Kharagpur 1997 - 2001
BTech (Hons), Chemical Engineering

Skills:

Manufacturing Strategy
Biotechnology
Process Simulation
Technology Transfer
Process Optimization
Process Engineering
Pharmaceutical Industry
Chemical Engineering
Cross-functional Team Leadership
Lifesciences
Six Sigma
Operational Excellence
GMP
Project Portfolio Management

Interests:

Mentor of the Life Sciences Track of UC Berkeley Business Plan Competition (2009 – 2010) *Advised two biotech start-ups based out of University of California, San Francisco in preparing marketing, operations and financial strategies as part of the business plan competition. Both teams were semi-finalists (2009 & 2010). Core team member of the Pittsburgh Action Center of Child Rights and You (CRY) (US-based non-profit supporting the rights of underprivileged children in India) * Raised $25,000 in funds over a 2-year period through organizing concerts and social events.

Honor & Awards:

Recent presentations: * “Production planning of batch and semi-continuous bioprocesses across multiple biopharmaceutical facilities”, to be presented at ESCAPE Conference (June 2012) * “Biotech Facility of the Future”, Invited Talk at the EPSRC Innovative Manufacturing Research Centre in Bioprocessing, University College London (July 2011). * Ghosh, S et al (2006) - Metabolic Engineering, Volume 8, Issue 5, September 2006, Pages 491-507 * Ghosh, S et al (2006) - Comput. Chem. Engg 29(3), pp. 459-466. – Specially invited publication to an Issue looking at innovative research in Systems Approaches to Biological Problem. * Zhu, T, Phalakornkule, C, Ghosh, S et al (2003) - Metabolic Engineering, Issue 5 pp. 74-85. * Ramanathan, SP, Mukherjee, S, Dahule, RK, Ghosh, S, et al (2001) - Chem. Engg. Res. & Des. 79(A3) pp. 310-322. * Nandi, S, Ghosh, S et al (2001) - AIChE J. 47(1) pp.126-141.

Languages:

Hindi
Bengali

President

view source

Location:

San Diego, CA

Industry:

Biotechnology

Work:

Avexegen Therapeutics
Co-Founder and Chief Strategy Officer
Doon Associates
President
Amylin Pharmaceuticals Apr 2003 - 2014
Executive Director
Peptide Therapeutics Foundation Apr 2003 - 2014
President
Mitokor 1994 - 2003
Senior Director, Chemical Biology

Education:

University of Chicago

Skills:

Drug Discovery
Biotechnology
Drug Development
Technology Transfer
Medicinal Chemistry
Pharmaceutical Industry
Clinical Development
Hplc
Lifesciences
Regulatory Submissions
Biopharmaceuticals
Oncology
Validation
Glp
Medical Devices
Ind
Amateur Photography
Protein Chemistry
R&D
Fda
Clinical Trials
Diabetes
Pharmacology
Commercialization
Life Sciences
Research and Development
U.s. Food and Drug Administration
Good Laboratory Practice

Soumitra Ghosh

view source

Soumitra Ghosh

view source

Location:

United States

Soumitra Ghosh

view source

Location:

United States

Us Patents

Diagnostic Method Based On Quantification Of Extramitochondrial Dna
view source
US Patent:

6441149, Aug 27, 2002
Filed:

Apr 30, 1999
Appl. No.:

09/302681
Inventors:

Corinna Herrnstadt - San Diego CA
Soumitra S. Ghosh - San Diego CA
William Clevenger - San Diego CA
Eoin D. Fahy - San Diego CA
Robert E. Davis - San Diego CA
Assignee:

Mitokor - San Diego CA
International Classification:

C07H 2102
US Classification:

536 231, 536 241, 536 243, 435 6
Abstract:

Compositions and methods based on quantification of extramitochondrial DNA (exmtDNA) sequences are provided that are useful for detecting the presence of or risk for having a disease associated with altered mitochondrial function, and for identifying agents suitable for treating such diseases. The exmtDNA sequences have strong homology to authentic mitochondrial DNA (mtDNA) sequences.

Diagnostic Method Based On Quantification Of Extramitochondrial Dna
view source
US Patent:

6489095, Dec 3, 2002
Filed:

Jun 15, 1998
Appl. No.:

09/098079
Inventors:

Corinna Herrnstadt - San Diego CA
Soumitra S. Ghosh - San Diego CA
William Clevenger - Vista CA
Eoin D. Fahy - San Diego CA
Robert E. Davis - San Diego CA
Assignee:

Mitokor - San Diego CA
International Classification:

C12Q 168
US Classification:

435 6, 435 911, 435 912, 435 915, 536 231, 536 243, 536 2431, 536 2432, 536 2433
Abstract:

Compositions and methods based on quantification of extramitochondrial DNA (exmtDNA) sequences are provided that are useful for detecting the presence of or risk for having a disease associated with altered mitochondrial function, and for identifying agents suitable for treating such diseases. The exmtDNA sequences have strong homology to authentic mitochondrial DNA (mtDNA) sequences.

Mitochondria Protecting Agents For Treating Mitochondria Associated Diseases
view source
US Patent:

6498191, Dec 24, 2002
Filed:

Dec 7, 2000
Appl. No.:

09/733271
Inventors:

Soumitra S. Ghosh - San Diego CA
Scott W. Miller - San Marcos CA
Robert E. Davis - San Diego CA
Walter H. Moos - Oakland CA
Assignee:

MitoKor - San Diego CA
International Classification:

A61K 31225
US Classification:

514547, 514648, 514721, 514741
Abstract:

The present invention relates generally to mitochondria protecting agents for treating diseases in which mitochondrial dysfunction leads to tissue degeneration and, more specifically, to compounds, compositions and methods related to the same. The methods of this invention involve administration of a pharmaceutically effective amount of a mitochondria protecting agent to a warm-blooded animal in need thereof, and composition of this invention contain a mitochondria protecting agent in combination with a pharmaceutically acceptable carrier or diluent. Mitochondrial associated diseases which may be treated by the present invention include (but are not limited to) Alzheimers Disease, diabetes mellitus, Parkinsons Disease, neuronal and cardiac ischemia, Huntingtons disease and stroke.

Mitochondria Protecting Agents For Treating Mitochondria Associated Diseases
view source
US Patent:

6511966, Jan 28, 2003
Filed:

Aug 20, 2001
Appl. No.:

09/933911
Inventors:

Soumitra S. Ghosh - San Diego CA
Scott W. Miller - San Marcos CA
Robert E. Davis - San Diego CA
Walter H. Moos - Oakland CA
Assignee:

MitoKor - San Diego CA
International Classification:

A01N 4304
US Classification:

514 34, 514312, 546168
Abstract:

The present invention relates generally to mitochondria protecting agents for treating diseases in which mitochondrial dysfunction leads to tissue degeneration and, more specifically, to compounds, compositions and methods related to the same. The methods of this invention involve administration of a pharmaceutically effective amount of a mitochondria protecting agent to a warm-blooded animal in need thereof, and composition of this invention contain a mitochondria protecting agent in combination with a pharmaceutically acceptable carrier or diluent. Mitochondrial associated diseases which may be treated by the present invention include (but are not limited to) Alzheimers Disease, diabetes mellitus. Parkinsons Disease, neuronal and cardiac ischemia. Huntingtons disease and stroke.

Compounds For Altering Mitochondrial Function And Cellular Responses
view source
US Patent:

6552076, Apr 22, 2003
Filed:

Dec 14, 2001
Appl. No.:

10/020090
Inventors:

Yazhong Pei - San Diego CA
Walter H. Moos - Oakland CA
Soumitra S. Ghosh - San Diego CA
Assignee:

MitoKor - San Diego CA
International Classification:

A61K 3124
US Classification:

514533, 560 22, 562405, 562433, 562444, 514534
Abstract:

Compounds for treating diseases by altering mitochondrial function that affects cellular processes, as well as to compositions and methods related thereto. The compounds have the structure wherein R , R , R and A are as defined herein.

Aryl-N-Cyanoguanidines And Methods Related Thereto
view source
US Patent:

6562821, May 13, 2003
Filed:

Feb 27, 2002
Appl. No.:

10/085119
Inventors:

Soumitra S. Ghosh - San Diego CA
Tomas R. Szabo - San Diego CA
Assignee:

MitoKor - San Diego CA
International Classification:

C07C27928
US Classification:

5142385, 514634, 544163, 564238, 564239
Abstract:

Compounds, compositions and methods treating arthritic disorders such as osteoarthritis or rheumatoid arthritis, and for treating other diseases associated with altered mitochondrial function, such as cancer, psoriasis, stroke, Alzheimers Disease and diabetes. The compounds of this invention have the following structure (I): including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein R are as defined herein. The methods of this invention are directed to administering to a warm-blooded animal in need thereof an effective amount of a compound of structure (I), typically in the form of a pharmaceutical composition.

Method Of Targeting Conjugate Molecules To Mitochondria
view source
US Patent:

6867197, Mar 15, 2005
Filed:

Nov 23, 1999
Appl. No.:

09/448312
Inventors:

Robert E. Davis - San Diego CA, US
Soumitra S. Ghosh - San Diego CA, US
John S. Kiely - San Diego CA, US
Assignee:

Mitokor - San Diego CA
International Classification:

A61K048/00
US Classification:

514 44, 514297, 435375
Abstract:

The present invention relates to genetic mutations in mitochondrial cytochrome c oxidase genes that segregate with Alzheimer's disease (AD). The invention provides methods for detecting such mutations, as a diagnostic for Alzheimer's Disease, either before or after the onset of clinical symptoms. The invention further provides treatment of cytochrome c oxidase dysfunction.

Production Of Adenine Nucleotide Translocator (Ant), Novel Ant Ligands And Screening Assays Therefor
view source
US Patent:

6887670, May 3, 2005
Filed:

Mar 14, 2001
Appl. No.:

09/811132
Inventors:

Christen M. Anderson - Encinitas CA, US
Robert E. Davis - San Diego CA, US
Tomas R. Szabo - San Diego CA, US
Soumitra S. Ghosh - San Diego CA, US
Walter H. Moos - Oakland CA, US
Yazhong Pei - San Diego CA, US
Assignee:

MIGENIX Corp. - San Diego CA
International Classification:

C07K001/00
C07K017/00
C07K001/14
C07K001/16
US Classification:

435 71, 435 691, 435 697, 530350, 530412, 530413, 536 231, 536 234, 536 235, 930 10
Abstract:

Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.